✦ LIBER ✦

P.1.g.085 Long-acting injectable risperidone and oral antipsychotics in patients with schizophrenia – a 1-year non-interventional study

✍ Scribed by Schreiner, A.; Svensson, A.; Wapenaar, R.; Cherubin, P.; Princet, P.; Serazetdinova, L.; Starostina, N.; Zink, M.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

1736 – Long-acting injectable risperidon

✍ Schreiner, A.; Svensson, A.; Wapenaar, R.; Cherubin, P.; Princet, P.; Serazetdin 📂 Article 📅 2013 🏛 Elsevier Science 🌐 French ⚖ 46 KB

Remission in schizophrenia: 1 year Itali

✍ A. Rossi; M.M. Bernareggi; M.G. Giustra 📂 Article 📅 2008 🏛 Elsevier Science 🌐 French ⚖ 42 KB

P.3.c.058 Interim-analysis of a long-ter

✍ B. Ibach; A. Schreiner 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 61 KB

P03-46 - Long-term safety, tolerability

✍ Ibach, B.; Rabinowitz, J.; Schreiner, A.; Hargarter, L.; Diekamp, B. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 French ⚖ 34 KB

Relapse and Long-Acting Injectable Rispe

✍ Kuan-Pin Su; Hui-Chih Chang; Shih-Jen Tsai; Feng-Chang Yen; Chao-Hsiun Tang 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 64 KB

A study of the efficacy and safety of sw

✍ Suzuki, H.; Inoue, Y.; Gen, K. 📂 Article 📅 2012 🏛 SAGE Publications 🌐 English ⚖ 733 KB